Key UK FRAND ruling imminent; PTAB reform bill confirmed; Battery patent war explodes; GSK’s $1.9bn for biotech IP innovator; Litigation finance peril; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week
Access all areas
With the latest news, analysis and data from the global IP market, an IAM subscription enables you to make effective decisions and advise with confidence. To learn more about how to secure full, unlimited access to the platform, contact [email protected]
The Long Read
China has detailed plans to build a “powerful IP nation”. This strong top-down signal has significant implications for policy and practice, writes Gowling WLG’s Jian Xu. Read more here
MONDAY 11 April
Vivo’s agreement to license a portfolio of 2G, 3G and 4G SEPs from Sisvel is the latest in a series of cellular deals the firm has secured with Chinese manufacturers. Read more here
German NPE IPCom has settled US litigation with a host of leading cellular network operators, including Verizon Wireless, AT&T, Sprint Spectrum and T-Mobile. Read more here
Although the USPTO has taken steps to terminate relations with the Russian patent office, there may still be wiggle room for patent applicants to pay Russia for international searches. Read more here
TUESDAY 12 April
The world’s leading battery maker for electronic vehicles is using both patent and unfair competition litigation to fend off rivals and halt brain drain. Read more here
The English High Court will shortly hand down its ruling in InterDigital v Lenovo, the first full FRAND trial heard in the UK since the Supreme Court’s judgment in the Unwired Planet case. Read more here
WEDNESDAY 13 April
The Full Bench of the Federal Court of Australia has overturned a highly-publicised first instance judgment and found that AI machine DABUS can’t be named as an inventor on a patent application. Read more here
Securities filings made by publicly-quoted NPE ParkerVision reveal the details and the risks involved in litigation finance deals. Read more here
THURSDAY 14 April
A current case in Germany shows how the ability to secure US discovery to help drive European IP litigation may be a very powerful – and underused – weapon. Read more here
The UK is a global innovation hub, but this is not reflected in British patenting activity. The country’s policy makers must work out why to prevent major opportunities being squandered. Read more here
Senators Patrick Leahy and Thom Tillis have confirmed that they will soon publish proposed legislation to reform the Patent Trial and Appeal Board. Read more here
FRIDAY 15 April
The patent litigation state of play between Nokia and Oppo, across nine jurisdictions in Europe and Asia, as the two parties compete for leverage in the renegotiation of their SEP deal. Read more here
Sierra Oncology, a late-stage biotech that has focused on acquiring unwanted IP from Big Pharma, is to be acquired by GlaxoSmithKline for $1.9 billion. Read more here
Two of the US’s busiest courts for patent itigation made news on Wednesday when President Biden announced his most recent slate of judicial nominees. Read more here
SATURDAY 16 April
How IP and commercial competition plays out in the batteries sector will tell us much about the future of globalised tech supply chains. Read more here
